Report Overview

The Canadian Contraceptive Market size stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of XX% during the forecast period.

The Canadian contraceptives market is expected to have noticeable growth during the analysis period due to the new launch of new drugs and products, prevention of pregnancy, growing government steps taken for abortions, and growing awareness among people. Oral contraceptives (OCs) have been available in Canada for more than 50 years and are the most commonly used method of reversible contraception. They are also among the medications most frequently used by Canadian women, three-quarters of whom takeOCs at some point in their lives. OCs include combined hormonal contraceptive pills, which contain both estrogen and progestin, and progestin-only pills.



Market Growth Drivers

The rising awareness in the regional population regarding contraception methods, investments by key players to develop innovative devices, and favorable government initiatives to improve access to products are the major factors accelerating the growth of the market. In addition, rising the prevalence of sexually transmitted diseases and the growing need for population control fuelling the regional market growth. Thus, the increasing diseases have increased the demand for contraceptive devices that is likely to aid market growth. Moreover, initiatives by governments to raise awareness regarding contraceptives and family planning have also helped the growth of the market. However, side effects associated with the use of Contraceptive devices hinder the market growth.